Interest of an auto-adjustable nighttime compression sleeve (MOBIDERMA (R) Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT

摘要

Purpose Breast cancer-related lymphedema (BCRL) is a debilitating condition. The recommended treatment is based on decongestive lymphedema therapy (DLT) with two separate phases: a short-term intensive phase to reduce lymphedema volume and a long-term maintenance phase to stabilize it. Optimizing compression therapy and compliance during maintenance phase are key factors for long-term control of lymphedema. The primary objective of this pilot prospective open-label randomized study was to assess the benefit of a new auto-adjustable nighttime arm sleeve (MOBIDERMA (R) Autofit) on lymphedema volume during the maintenance phase after the intensive phase.